Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Science

CYTOO launches 2D+ Solutions at High Content Analysis (HCA), January 08-11, 2013


Print article Print article

2013-01-02 11:12:27 - CYTOO’s 2D+ Solutions open fresh perspectives for cell based assay development in drug discovery

Grenoble, France, 2nd January 2013 – CYTOO, a life science systems & tools company providing disruptive solutions for cell-based assays and High Content Screening (HCS), will launch the 2D+ Solutions at the High Content Analysis (HCA) Annual Meeting in San Francisco. .

CYTOO’s 2D+ Cell Culture Platform is based on standard and custom adhesive micropatterns in 96-well plates to guide cell architecture and behavior in culture. By defining the 2D topology of cell adhesion, the 2D+ Cell Culture Platform enables fine control of the spreading and 3D shape of cultured cells in single- or multi-cellular configurations. This approach results in control of cell contractility, cell polarity, organelle positioning, and cell division axis. This technology addresses a major concern with traditional 2D

culture, in which cells spread and move in an uncontrolled manner, introducing a considerable but unnoticed variability in cell function.

CYTOO’s Custom Solutions bring expertise, resources and technology to address current bottlenecks in cell based assay development and screening. 2D+ Custom Solutions begin with an in-depth analysis of the customer’s assay, by experienced PhD-level experts of the 2D+ technology.

The 2D+ Custom Solutions process includes: Exploratory solutions to guide customers through the initial exploration of the 2D+ technology; Assay development to select the best ecosystem for the requested cells; Screening to run small and medium screens.

Attendees are invited to visit HCA booth #24 to discuss their application with Pauline Poydenot, Head of Cell Assay Services, and Myles Fennell, Application Development Leader.
For more information, visit www.cytoo.com

About CYTOO S.A.
CYTOO is a distinctive life sciences systems & tools company offering disruptive solutions for cell-based assays and High Content Screening (HCS) that reinforce robustness, sensitivity and powerful quantification. The Company’s 2D+ Cell Culture Platform and Custom Solutions are based on adhesive micropatterns, offering control over the cells' microenvironment, leading to normalized cell morphology and behavior. The technology allows the optimization or resurrection of complex or difficult cell-based assays and enables innovative assay development.

For more information about the complete product portfolio, visit www.cytoo.com

Contact: afuchs@cytoo.com, +33 (0)4 38 88 47 07

Follow us!

twitter.com/CYTOO
www.linkedin.com/company/cytoo-cell-architects
www.facebook.com/cytoo.cellarchitects


Contact Information:
CYTOO

7 parvis Louis Néel
Batiment BHT
BP 50, 38040 Grenoble

FRANCE

Contact Person:
Chloe Loiraud
Community manager
Phone: + 33 438 884 705
email: email

Web: www.cytoo.com



Author:
Chloe Loiraud
e-mail
Web: www.cytoo.com
Phone: 0438884723

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser